BioSpace News Archive

89bio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, reported its financial results for the quarter ended March 31, 2022.

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today reported financial results for the first quarter ended March 31, 2022 and provided corporate updates.

Cue Biopharma, Inc. (Nasdaq: CUE), today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s Investigational New Drug (IND) application for the evaluation of CUE-102, its second interleukin 2 (IL-2)-based CUE-100 series biologic, in a dose escalation and expansion monotherapy Phase 1 trial.

Koelis, SAS, a leader and innovator in the care of prostate cancer, announced the launch of new products at the prestigious American Urological Association Annual Meeting in New Orleans, LA.

ENA Respiratory, a clinical-stage pharmaceutical company developing INNA-051, a first-in-class broad-spectrum antiviral innate immunomodulator for pan-antiviral prophylaxis in at-risk populations and pandemic preparedness, has been selected to join BLUE KNIGHT™, a joint initiative between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA), a component of the U.S. Department of Health and Human Services

Ocuphire Pharma, Inc. announced presentations by Mina Sooch, Founder and CEO, at the New Pathways in Retinal Diseases Panel at Retina World Congress on May 12, 2022 and at H.C. Wainwright Global Investment Conference on May 24, 2022.

Genmab Announces Financial Results for the First Quarter of 2022.

Lung disease is now a leading cause of death in the country due to the increase in COVID-19 infections and related deaths.

IRLAB Therapeutics AB’s Annual General Meeting 2022 was held, Wednesday May 11, 2022, at Wallenbergs Konferenscentrum, Medicinaregatan 10 A in Göteborg.

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS 2022 Global Healthcare Conference.